Perspectives of Implementing "Green Chemistry" Principles in Pharmaceutical Production Technology

Abstract

The pharmaceutical industry, while critical to global health, is historically associated with severe environmental impacts, primarily due to the generation of massive volumes of chemical waste, high energy consumption, and the reliance on toxic, non-renewable solvents. This paper explores the perspectives of integrating "Green Chemistry" principles into pharmaceutical production technologies. We provide a comprehensive analysis of fundamental metrics such as the Environmental Factor (E-factor) and Atom Economy, alongside a detailed evaluation of modern green technologies, including biocatalysis, alternative green solvents (ionic liquids and supercritical fluids), microwave-assisted synthesis, and continuous flow manufacturing. Furthermore, this research critically assesses the technological, economic, and regulatory barriers to the adoption of these sustainable methodologies. A specific regional focus is dedicated to the Republic of Kazakhstan, evaluating the current landscape, identifying strategic opportunities through a SWOT analysis, and proposing actionable recommendations for local pharmaceutical enterprises and policymakers to facilitate the transition toward ecological sustainability.